Assay Detail
Binding
CHEMBL5121197
Review assay metadata, readout intent, target linkage, and publication context from the same page.
Antagonist activity at ERbeta (unknown origin)
38
Total Activities
19
Compounds Tested
2
Activity Types
0
Assay Parameters
Assay Information
| Assay Type | Binding |
| Organism | Homo sapiens |
| Confidence | 9 — Direct single protein target |
| Curated By | Autocuration |
Publication
Human estrogen receptor α antagonists, part 2: Synthesis driven by rational design, in vitro antiproliferative, and in vivo anticancer evaluation of innovative coumarin-related antiestrogens as breast cancer suppressants.
Activity Statistics
| Type | Count | Avg pChEMBL | Best pChEMBL |
|---|---|---|---|
| IC50 | 19 | 7.16 | 9.05 |
| Ka | 19 | - | - |
Compounds Tested
| Compound | Name | Phase | Activities | Best pChEMBL |
|---|---|---|---|---|
| CHEMBL135 | ESTRADIOL | 4.0 | 2 | 9.05 |
| CHEMBL489 | AFIMOXIFENE | 3.0 | 2 | 8.44 |
| CHEMBL5209099 | — | — | 2 | 7.54 |
| CHEMBL5194045 | — | — | 2 | 7.50 |
| CHEMBL5196340 | — | — | 2 | 7.43 |
| CHEMBL5174813 | — | — | 2 | 7.37 |
| CHEMBL5198828 | — | — | 2 | 7.34 |
| CHEMBL5178110 | — | — | 2 | 7.21 |
| CHEMBL5191405 | — | — | 2 | 7.17 |
| CHEMBL5203282 | — | — | 2 | 7.16 |
| CHEMBL5181808 | — | — | 2 | 7.14 |
| CHEMBL5187730 | — | — | 2 | 7.13 |
| CHEMBL5178058 | — | — | 2 | 7.11 |
| CHEMBL5195371 | — | — | 2 | 7.10 |
| CHEMBL5187253 | — | — | 2 | 7.06 |
| CHEMBL5184399 | — | — | 2 | 7.01 |
| CHEMBL5199803 | — | — | 2 | 6.99 |
| CHEMBL5207726 | — | — | 2 | 5.24 |
| CHEMBL81 | RALOXIFENE | 4.0 | 2 | 5.13 |
Activity Data
| Compound | Name | Type | Rel. | Value | Units | pChEMBL |
|---|---|---|---|---|---|---|
| CHEMBL135 | ESTRADIOL | IC50 | = | 0.89 | nM | 9.05 |
| CHEMBL489 | AFIMOXIFENE | IC50 | = | 3.61 | nM | 8.44 |
| CHEMBL5209099 | — | IC50 | = | 28.82 | nM | 7.54 |
| CHEMBL5194045 | — | IC50 | = | 31.87 | nM | 7.50 |
| CHEMBL5196340 | — | IC50 | = | 36.78 | nM | 7.43 |
| CHEMBL5174813 | — | IC50 | = | 42.73 | nM | 7.37 |
| CHEMBL5198828 | — | IC50 | = | 45.43 | nM | 7.34 |
| CHEMBL5178110 | — | IC50 | = | 62.09 | nM | 7.21 |
| CHEMBL5191405 | — | IC50 | = | 67.14 | nM | 7.17 |
| CHEMBL5203282 | — | IC50 | = | 69.88 | nM | 7.16 |
| CHEMBL5181808 | — | IC50 | = | 72.48 | nM | 7.14 |
| CHEMBL5187730 | — | IC50 | = | 74.46 | nM | 7.13 |
| CHEMBL5178058 | — | IC50 | = | 77.53 | nM | 7.11 |
| CHEMBL5195371 | — | IC50 | = | 79.54 | nM | 7.10 |
| CHEMBL5187253 | — | IC50 | = | 86.41 | nM | 7.06 |
| CHEMBL5184399 | — | IC50 | = | 98.25 | nM | 7.01 |
| CHEMBL5199803 | — | IC50 | = | 102.47 | nM | 6.99 |
| CHEMBL5207726 | — | IC50 | = | 5732.0 | nM | 5.24 |
| CHEMBL81 | RALOXIFENE | IC50 | = | 7430.0 | nM | 5.13 |
| CHEMBL5178058 | — | Ka | = | 43.56 | nM | - |
| CHEMBL5209099 | — | Ka | = | 16.19 | nM | - |
| CHEMBL5184399 | — | Ka | = | 55.2 | nM | - |
| CHEMBL5198828 | — | Ka | = | 25.52 | nM | - |
| CHEMBL5187253 | — | Ka | = | 48.54 | nM | - |
| CHEMBL5196340 | — | Ka | = | 20.66 | nM | - |
| CHEMBL5199803 | — | Ka | = | 57.57 | nM | - |
| CHEMBL5181808 | — | Ka | = | 40.72 | nM | - |
| CHEMBL5187730 | — | Ka | = | 41.83 | nM | - |
| CHEMBL5195371 | — | Ka | = | 44.69 | nM | - |
| CHEMBL5174813 | — | Ka | = | 24.01 | nM | - |
| CHEMBL5207726 | — | Ka | = | 32.2 | nM | - |
| CHEMBL5203282 | — | Ka | = | 39.26 | nM | - |
| CHEMBL5178110 | — | Ka | = | 34.88 | nM | - |
| CHEMBL5191405 | — | Ka | = | 37.72 | nM | - |
| CHEMBL5194045 | — | Ka | = | 17.9 | nM | - |
| CHEMBL135 | ESTRADIOL | Ka | = | 0.5 | nM | - |
| CHEMBL489 | AFIMOXIFENE | Ka | = | 2.03 | nM | - |
| CHEMBL81 | RALOXIFENE | Ka | = | 41.24 | nM | - |